Market Insight

Markets rarely move at random. InvestorPlace’s leading analysts break down macro trends, sector dynamics, and recurring market patterns to help investors understand what is changing, what matters most, and where opportunities may emerge.

Exxon (XOM) CEO Discusses Impact of Weak Dollar

By Douglas McIntyre, Co-Founder & Editor, 24/7 Wall St.
Exxon Mobil (XOM) CEO Rex Tillerson this morning said that the weak U.S. dollar is adding $20-$25 to the price of a barrel of oil. The XOM chief's comments show just how weak the dollar is.

Is Frugal Out? Luxury Retail Stocks In

By Jim Woods, Editor-in-Chief, Successful Investing, Intelligence Report, Bullseye Stock Trader
Retail stocks like Wal-Mart (WMT) and Kohl's (KSS) reported better than expected earnings this week, but it will be the luxury retailers like Nordstrom (JWM), Tiffany (TIF) and Coach (COH) that will be winners for investors going forward.

DryShips (DRYS) to Rise with Market Tide

By Douglas McIntyre, Co-Founder & Editor, 24/7 Wall St.
DryShips (DRYS) is closing in on $7 a share. Here are the forces lifting DRYS higher.

Dow Chemical (DOW) Sets New High

By Douglas McIntyre, Co-Founder & Editor, 24/7 Wall St.
Dow Chemical (DOW) reached a 52-week high today after agreeing to sell its powder coating business to Dutch-based Akzo Nobel NA. Here's what the sale means for DOW stock.

What’s Next for Blockbuster (BBI)?

By Douglas McIntyre, Co-Founder & Editor, 24/7 Wall St.
Blockbuster (BBI) reports earnings tomorrow, and the numbers will not be good. How did Netflix (NFLX), Redbox (CSTR), Apple (AAPL) and Amazon (AMZN) knock Blockbuster off its throne as king of the movie delivery business?

Gold Mining Stocks Yamna Gold (AUY), Barrick Gold (ABX), Newmont Mining (NEM) Surge

By Douglas McIntyre, Co-Founder & Editor, 24/7 Wall St.
With spot gold prices touching $1,100 an ounce, gold stocks like Yamna Gold (AUY), Barrick Gold (ABX) and Newmont Mining (NEM) are surging.

Vonage (VG) Should Be Doing Better

By Douglas McIntyre, Co-Founder & Editor, 24/7 Wall St.
Vonage (VG) has given investors a wild ride this year. Is VG doomed to be a penny stock?

Starbucks (SBUX) Turns in a Fresh Pot of Profits

By Jim Woods, Editor-in-Chief, Successful Investing, Intelligence Report, Bullseye Stock Trader
Starbucks (SBUX) turned in a stellar earnings report today. Does that mean it's time to buy SBUX? And what about Peet's (PEET), Diedrich (DDRX), Green Mountain (GMCR) and Caribou (CBOU)?

Delta Petroleum (DPTR) Trying to Make Lemonade

By Douglas McIntyre, Co-Founder & Editor, 24/7 Wall St.
Delta Petroleum (DPTR) reported earnings that were far below analysts' expectations today. Here's what it means for the stock.

Weak Dollar Leads India To Stock Up on Gold

By Douglas McIntyre, Co-Founder & Editor, 24/7 Wall St.
India bought 200 metric tons of gold for $6.7 billion yesterday, citing the collapse of U.S. and European economies. The weak dollar and rising crude prices are behind India's decision.

9 Top iPhone Apps for Traders

By Jim Woods, Editor-in-Chief, Successful Investing, Intelligence Report, Bullseye Stock Trader
Want to trade stocks and options, but you're nowhere near your home or office computer? No problem, there's an app for that.

Stock Market Sell-off – The Market is Headed Off a Cliff

By Chris Rowe
The odds strongly favor a continued stock market sell-off -- and I mean a big one.

Buffett Burlington Northern (BNI) Deal Sets New Floor For Rail Valuations

By Douglas McIntyre, Co-Founder & Editor, 24/7 Wall St.
Warren Buffett is acquiring Burlington Northern Sante Fe (BNI) in a $44 billion deal. Will this set a new valuation for the rail sector?

Comcast (CMCSA) to Give NBC New Home

By Douglas McIntyre, Co-Founder & Editor, 24/7 Wall St.
Comcast (CMCSA) is closer to gaining ownership of NBC Universal from GE. But other companies in the industry like Time Warner (TWX) have learned that controlling distribution and content is not the synergy Comcast hopes it will be.

Human Genome Sciences (HGSI) – What’s Ahead After Positive Lupus Study?

By Douglas McIntyre, Co-Founder & Editor, 24/7 Wall St.
Human Genome Sciences (HGSI) stock soared after news that Benlysta, its drug for lupus, met primary endpoints. What's ahead for HGSI?

Chinese Solar Maker LDK Solar (LDK) Gets a Lesson in Hardball

By Douglas McIntyre, Co-Founder & Editor, 24/7 Wall St.
LDK Solar (LDK), the Chinese solar PV wafer maker is in a dispute with German solar panel maker Q-Cells SE. Q-Cells seems to be giving the China stock a lesson in playing hardball.

Exxon (XOM) Earnings Highlight Big Oil Troubles

By Douglas McIntyre, Co-Founder & Editor, 24/7 Wall St.
Exxon (XOM) reported earnings today that did not meet consensus estimates. The XOM earnings report highlights why big oil is in the doldrums.

Cosmetics Stocks EL, REV, RDEN Can Make Your Portfolio Beautiful

By Jim Woods, Editor-in-Chief, Successful Investing, Intelligence Report, Bullseye Stock Trader
Estee Lauder (EL) reported better than expected earnings today. Here's why El, Revlon (REV) and Elizabeth Arden (RDEN) are poised for more gains.

How to Profit from the Gold Frenzy

By Jim Woods, Editor-in-Chief, Successful Investing, Intelligence Report, Bullseye Stock Trader
Barrick Gold Corp. (ABX) and Newmont Mining (NEM) both reported better-than-expected earnings yesterday. But gold stocks have already enjoyed quite a run. Is it too late to cash in on gold?
Load More Articles